Can you be on Wegovy forever? What the evidence actually says

Wegovy is licensed in the UK for long-term weight management alongside a reduced-calorie diet and increased physical activity — there is no fixed maximum duration written into the licence.
NICE guidance (TA875) recommends semaglutide be used for a maximum of two years within NHS specialist weight management services; private use is not capped by this recommendation in the same way.
Regaining weight after stopping is well-documented: the STEP 1 extension trial showed most participants regained the majority of lost weight within a year of discontinuation.
Regular clinical review matters: a prescriber should reassess tolerability, continued benefit and any changes in health status before every repeat supply.

Wegovy (semaglutide 2.4mg) is not meant to be a short course. Clinical evidence and UK licensing position it as a long-term treatment: the weight it helps you lose tends to return if you stop, which is why many people do stay on it for years. That said, what Wegovy is approved for in the UK and whether you can be on it indefinitely are two slightly different questions — and the honest answer is: it depends on your clinical picture, not a blanket rule. These are prescription-only medicines, and how long any person continues is a decision made with their prescriber, reviewed regularly.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How long-term Wegovy use actually works, and what happens when it stops

Is there a time limit on using Wegovy in the UK?

The UK product licence for Wegovy does not set a hard stop date. It is authorised for adults with a BMI of 30 or above (or 27 or above with at least one weight-related condition) as an ongoing treatment alongside lifestyle changes. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance. In that sense, the medicine itself carries no built-in expiry.

Where a time limit does enter the picture is on the NHS. NICE's appraisal of semaglutide (TA875) recommends it only within specialist NHS weight management services and for a maximum of two years, partly to manage NHS budgets, partly because the long-term evidence base at the time of appraisal was shorter. That two-year cap applies to that specific NHS pathway. It does not mean the medicine becomes unsafe or unlicensed after 24 months; it means NHS funding through that route ends.

For people using Wegovy privately through a regulated online pharmacy, continuity is governed by ongoing clinical suitability rather than a calendar. A prescriber will look at whether you are still benefiting, whether the medicine is well tolerated, and whether your health circumstances have changed. If the answer to all three is straightforward, there is no clinical reason to stop simply because time has passed. Understanding what typical Wegovy weight loss looks like can help set realistic expectations for the long term.

What actually happens to your weight if you stop Wegovy?

This is probably the question underneath your question, and it deserves a straight answer. Obesity is a chronic condition with biological drivers (hormones, appetite signalling, metabolic rate) that do not reset permanently just because weight has been lost. Wegovy works partly by acting on GLP-1 receptors involved in appetite and fullness. When you stop, those effects stop too.

The evidence on this is consistent. In the STEP 1 extension study, participants who completed the 68-week treatment and then discontinued regained on average around two-thirds of the weight they had lost within 12 months, and most of the metabolic improvements reversed as well. The original STEP 1 trial, published in the New England Journal of Medicine, reported an average of around 15% body weight reduction over 68 weeks, a result that largely depended on continued treatment.

This is not a failure of willpower. It reflects how the condition works. Many people also find themselves asking whether staying on Wegovy indefinitely is a realistic and safe option, and it is a question worth exploring carefully with your prescriber. Thinking about whether you need to take Wegovy long-term is a legitimate part of planning treatment, and your prescriber can help you weigh the evidence against your own goals.

Does taking Wegovy for years raise any safety concerns?

Long-term use is something our prescribers take seriously, and it is worth being clear about what we know. Semaglutide has now been used in large-scale trials and real-world populations for several years, and the safety profile observed in studies of two years and beyond is broadly consistent with the well-characterised side-effect profile from shorter trials.

The most common effects remain gastrointestinal: nausea, loose stools, constipation, reflux and reduced appetite, typically most noticeable at the start of treatment or after a dose increase and settling over time for most people. Wegovy carries a Black Triangle (▼) designation from the MHRA, meaning it is subject to additional monitoring, any suspected side effects can and should be reported at the MHRA's Yellow Card scheme. On the positive side, longer-duration evidence increasingly shows cardiovascular benefits for eligible patients.

Regular review is the safeguard. Before any repeat supply from a regulated pharmacy, a clinician should reassess. That is not box-ticking; it is how ongoing suitability is genuinely confirmed. If you have questions about your own situation, our team is available seven days a week.

So can you stay on Wegovy forever, and should you?

If you are wondering whether you will be on this medicine for the rest of your life, that is a completely understandable thing to sit with. There is no shame in it, and it does not mean the treatment has failed or that you have.

The clinical position is pragmatic: for many people, Wegovy works best as a long-term tool, not a fixed course. Many patients ask whether it is realistic to take Wegovy forever, and the honest answer is that it depends on individual health, response, and goals, rather than any fixed rule. The question of whether you have to take Wegovy forever is similarly personal, shaped by your weight, your health, how you feel on it, and your own priorities, and it is best explored as an ongoing clinical conversation with your prescriber.

What matters most right now is that any continuation is clinically reviewed, not automatic. You can read more about weight-loss treatment options at nume, or if you are ready to talk through your specific situation, speaking to our prescribers is the right next step. Start your free consultation at our treatment page, a real clinician, not software, reads every response the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions